Cite

HARVARD Citation

    Hober, C. et al. (2021). Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab. Therapeutic advances in medical oncology. p. . [Online]. 
  
Back to record